Eric Groen's most recent trade in Genelux Corp was a trade of 270,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Genelux Corp | Eric Groen | General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 270,000 | 270,000 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings... | Eric Groen | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 323,500 | 323,500 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings... | Groen Eric | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2023 | 171,500 | 171,500 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings... | Eric Groen | General Counsel | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 Dec 2023 | 171,500 | 34,300 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings... | Groen Eric | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2023 | 54,167 | 54,167 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings... | Eric Groen | General Counsel | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 Dec 2023 | 54,167 | 75,833 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings... | Groen Eric | General Counsel | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 Dec 2023 | 43,400 | 31,000 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings... | Eric Groen | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2023 | 43,400 | 43,400 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings... | Eric Groen | GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 205,800 | 205,800 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings... | Eric Groen | GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 139,000 | 163,216 | - | 0 | Class A Common Stock | |
| Rani Therapeutics Holdings... | Eric Groen | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.95 per share. | 22 Mar 2023 | 2,498 | 24,216 | - | 5.9 | 14,863 | Class A Common Stock |
| Rani Therapeutics Holdings... | Eric Groen | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 74,400 | 74,400 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings... | Eric Groen | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 24,500 | 24,500 | - | 0 | Class A Common Stock |